Provided herein are methods for treating or preventing drug-resistant hepatitis C virus infection in a subject, which comprises administering to the subject a 5,5-fused heteroarylene hepatitis C virus inhibitor compound, for example, of Formula I, IA, or IB.
本文提供了一种治疗或预防受体内药物耐药性丙型肝炎病毒感染的方法,包括向受体内注射一种5,5-融合杂
芳烃丙型肝炎病毒
抑制剂化合物,例如,公式I、IA或IB中的化合物。